EurekaBio raised $40M in a Series B+ funding led by Yeuxiu Industrial Fund to support the commercialization of its EuLV™ Lentiviral Vector Production System.
Mar 10, 2024•almost 2 years ago
Amount Raised
$40 Million
Round Type
series b
ShenzhenBiotechnologyInvestors
Us FundsChina FundsYeuxiu Industrial Fund
Description
EurekaBio closed a $40 million Series B+ funding led by Yeuxiu Industrial Fund to support the commercialization of its EuLV™ Lentiviral Vector Production System, a technology that the company believes could transform large-scale production of lentiviral vectors.
Funding Insights
Based on industry dataVC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech